The only tests thus far approved by the FDA in the USA and China include the DNA methylation-based test of SEPT9 for the detection of colorectal cancer [131,132] and the qPCR-based test for mutated EGFR in NSCLC [133]. Here, EGFR is linked to non-small cell lung carcinoma.